首页> 美国卫生研究院文献>other >Overproduction of lactimidomycin by cross-overexpression of genes encoding Streptomyces antibiotic regulatory proteins
【2h】

Overproduction of lactimidomycin by cross-overexpression of genes encoding Streptomyces antibiotic regulatory proteins

机译:通过交叉表达编码链霉菌抗生素调节蛋白的基因过量生产乳嘧啶霉素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The glutarimide-containing polyketides represent a fascinating class of natural products that exhibit a multitude of biological activities. We have recently cloned and sequenced the biosynthetic gene clusters for three members of the glutarimide-containing polyketides – iso-migrastatin (iso-MGS) from Streptomyces platensis NRRL 18993, lactimidomycin (LTM) from Streptomyces amphibiosporus ATCC 53964, and cycloheximide (CHX) from Streptomyces sp. YIM56141. Comparative analysis of the three clusters identified mgsA and chxA, from the mgs and chx gene clusters, respectively, that were predicted to encode the PimR-like Streptomyces Antibiotic Regulatory Proteins (SARPs), but failed to reveal any regulatory gene from the ltm gene cluster. Overexpression of mgsA or chxA in S. platensis NRRL 18993, S. sp. YIM56141 or SB11024, a recombinant strain of Streptomyces coelicolor M145 carrying the intact mgs gene clusters, has no significant effect on iso-MGS or CHX production, suggesting that MgsA or ChxA regulation may not be rate limiting for iso-MGS and CHX production in these producers. In contrast, overexpression of mgsA or chxA in S. amphibiosporus ATCC 53964 resulted in significant increase in LTM production, with LTM titer reaching 106 mg/L, which is five-fold higher than that of the wild-type strain. These results support MgsA and ChxA as members of the SARP family of positive regulators for the iso-MGS and CHX biosynthetic machinery and demonstrate the feasibility to improve glutarimide-containing polyketide production in Streptomyces strains by exploiting common regulators.
机译:含戊二酰亚胺的聚酮化合物代表了令人着迷的一类天然产物,具有多种生物活性。我们最近克隆了含戊二酰亚胺的聚酮化合物的三个成员的生物合成基因簇,并对其进行了测序-链霉菌NRRL 18993的异米格他汀(iso-MGS),两栖链霉菌ATCC 53964的乳酸亚霉素(LTM)和环己酰亚胺(CHX)链霉菌YIM56141。对这三个簇的比较分析分别从mgs和chx基因簇中鉴定出mgsA和chxA,它们被预测为编码PimR样链霉菌抗生素调节蛋白(SARPs),但未能从ltm基因簇中揭示任何调节基因。 。 S. platensis NRRL 18993,S. sp。中的mgsA或chxA过表达。 YIM56141或SB11024是携带完整mgs基因簇的天蓝色链霉菌M145的重组菌株,对iso-MGS或CHX的产生没有显著作用,表明MgsA或ChxA调控可能不是这些中对iso-MGS和CHX产生的速率限制。生产者。相反,在 S中mgsA或 chxA 的过表达。 amphibiosporus ATCC 53964大大提高了LTM产量,LTM滴度达到106 mg / L,比野生型菌株高五倍。这些结果支持MgsA和ChxA成为iso-MGS和CHX生物合成机制的SARP正调节剂家族的成员,并证明通过利用常见调节剂改善链霉菌菌株中含戊二酰亚胺的聚酮化合物生产的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号